Groote Schuur Hospital
Cape Town, Western Province, 7925, South Africa
NCT Number: NCT03505047
The main objective of the study is to compare use, in a randomised controlled trial, of the the copper IUD if inserted immediately after completion of a second trimester medical abortion, to standard care with insertion 3-4 or more weeks after abortion at community health centres.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Cape Town, Western Province, 7925, South Africa
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Immediate insertion of the copper intrauterine device after completion of abortion
Time frame: 6 weeks after second trimester abortion
Number of women using the IUD
Time frame: 6 weeks after second trimester abortion
Number of IUD insertions
Time frame: 3 months after second trimester medical abortion
Number of women using the IUD
Time frame: 6 months after second trimester medical abortion
Number of women using the IUD
Time frame: 6 weeks post-abortion
Number of full and partial expulsions
Time frame: Between 6 weeks and 3 months post abortion
Number of full and partial expulsions
Time frame: Between 3 and 6 months post abortion
Number of full and partial expulsions
Time frame: within 3 and 6 months post-abortion
Number of removals
Time frame: within 3 months post-abortion
Number of complications
Time frame: Reported at 3 and 6 months post-abortion
5 point scales
Time frame: At 6 months post-abortion
Number of recurrent pregnancies
University of Cape Town
Other
Immediate Versus Delayed Insertion of the Copper IUD After Second-trimester Medical Abortion - a Randomised Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06557499
Contraception
Berkeley, California, United States
View Trial DetailsNCT07326007
Contraception
Giza, Egypt
View Trial DetailsNCT05732142
Contraception, Gender Equity
La Jolla, California, United States
View Trial DetailsNCT03127722
Contraception
Chandler, Arizona, United States
View Trial Details